Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality worldwide. 1 initial antibiotic therapy is the mainstay of management. Selection of appropriate and effective antibiotic treatment is crucial to reduce misuse, resistance, and side effect of antibiotics. 2 The present infographic illustrates the causative pathogen and risk factors for CAP and the role of ceftaroline fosamil in the management of CAP.
PP-ZFO-IND-0096 05 Aug 2020 The previous article describes the epidemiology, disease burden, treatment challenges in CAP, and highlights management strategies. Click here to read.! The next article discusses the patient treatment journey and emerging antibiotic therapies for CAP. Click here to read.!